Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/103789
DC FieldValueLanguage
dc.contributor.authorFerreira, Pedro L.-
dc.contributor.authorLuzeiro, Isabel-
dc.contributor.authorLopes, Margarida-
dc.contributor.authorJorge, André-
dc.contributor.authorSilva, Bruno-
dc.contributor.authorFerreira, Lara-
dc.date.accessioned2022-11-28T10:59:25Z-
dc.date.available2022-11-28T10:59:25Z-
dc.date.issued2021-02-06-
dc.identifier.issn1471-2377-
dc.identifier.urihttps://hdl.handle.net/10316/103789-
dc.description.abstractBackground: Migraine Disability Assessment Scale (MIDAS) is a useful tool to measure headache-related disability. Modified MIDAS with 4-week recall period reduces recall bias and improves accuracy of the results. This study aimed at validating mMIDAS in Portuguese. Methods: Studied population consisted of adult migraine patients attending a headache outpatient clinic. Reliability was assessed by internal consistency and reproducibility in a 3-week test-retest. Content validity was evaluated by two expert panels. Construct validity was tested by comparing mMIDAS-P index in socioeconomic and clinical patient groups and scale unidimensionality was evidenced by factor analysis. Criterion validity was tested using EQ-5D-5L and HADS. Results: Ninety-two patients, 88% female, mean age of 44 years, participated. They had, in average, 9.7 headache days in previous month, pain averaging 7.5/10. About 69.9% were on a migraine prophylactic treatment, and 42.4% had severe disability; 29.4 and 13.0% showed, respectively, moderate/severe anxiety and depression. Content validity showed that mMIDAS-P is simple and clinically useful. It did not show to be determined by patient’s sociodemographic characteristics and it was correlated with depression scale and EQ-5D-5L. Test-retest demonstrated high reproductive reliability and good internal consistency. Conclusion: mMIDAS-P is valid and reliable. We strongly recommend it for clinical and research use.pt
dc.language.isoengpt
dc.publisherSpringer Naturept
dc.relationNovartis Farma - research grantpt
dc.relationCEISUC/CIBB is funded by national funds through FCT - Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectPatient reported outcomespt
dc.subjectQuality of life, Migrainept
dc.subjectmMIDAS-Ppt
dc.subjectProductivity, Disabilitypt
dc.titleValidity and reliability of the Portuguese version of the modified Migraine Disability Assessmentpt
dc.typearticlept
degois.publication.firstPage58pt
degois.publication.issue1pt
degois.publication.titleBMC Neurologypt
dc.peerreviewedyespt
dc.identifier.doi10.1186/s12883-021-02085-z-
degois.publication.volume21pt
dc.date.embargo2021-02-06*
dc.identifier.pmid33549045-
uc.date.periodoEmbargo0pt
dc.identifier.eissn1471-2377-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCEISUC - Center for Health Studies and Research of the University of Coimbra-
crisitem.author.orcid0000-0002-9448-9542-
Appears in Collections:I&D CEISUC - Artigos em Revistas Internacionais
Show simple item record

SCOPUSTM   
Citations

2
checked on Apr 29, 2024

WEB OF SCIENCETM
Citations

2
checked on May 2, 2024

Page view(s)

52
checked on May 8, 2024

Download(s)

30
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons